Thank you very much for your question.
Investment is chronically insufficient. I think the level of investment is totally insufficient, especially when it comes to strategic investment. For example, if we ask how many millions of dollars the Canadian Institutes of Health Research, or CIHR, or granting agencies have invested in AMR research, the figures are often an overestimate of what is actually happening, because it's often in open programs. This means that any project with a theme related to AMR will be considered in this budget.
However, if we really want to have a strategy that is designed to align specifically with actions that are identified, for example, by public health and in the Pan-Canadian Action Plan on Antimicrobial Resistance, we need more concerted investment. For example, when it comes to human health research and the CIHR, $1.8 million doesn't go very far. I think that if we really want to be able to deliver on and implement the strategy that is currently being developed, this is clearly not enough to have an impact.
